Coronavirus outbreak: AstraZeneca approaches Gilead about potential merger

Gilead was contacted last month by AstraZeneca about the possibilities
of merger. In case the deal happens, it would bring together two firms
leading the drug industry’s efforts to fight the coronavirus pandemic